The purposes of this clinical trial are to test 1. Whether 1-week rifaximin treatment is able to restore the gut microbiota in a long-term manner in people with Parkinson's disease? 2. Whether the restoration of gut microbiota in people with Parkinson's disease is associated with the reduction of systemic inflammation and circulating exosomal α-synuclein?
Modulation of Gut Microbiota by Rifaximin... - Cure Parkinson's
Modulation of Gut Microbiota by Rifaximin in PD Patients
Written by
Farooqji
To view profiles and participate in discussions please or .
Read more about...
Not what you're looking for?
You may also like...
Must Read: Gut Microbiota: A Novel Therapeutic Target for Parkinson’s Disease 24 June 2022
dysbiotic gut microbiota can aggravate PD pathology, while re-establishment of the gut microbiota...
Oral berberine improves brain dopa/dopamine levels to ameliorate Parkinson’s disease by regulating gut microbiota
levels to ameliorate Parkinson’s disease by regulating gut microbiota
Yan Wang, Qian Tong, Shu-Rong...
Fascinating Read: Mitochondria-Microbiota Interaction in Neurodegeneration 2021
Mitochondria-Microbiota Interaction in Neurodegeneration 2021...
Vitamin B1 dose for an early PD patient?
days as recommended by Daphne Bryan in her book Parkinson's and the B1 Therapy.
Though it's...
Reductions in fecal short-chain fatty acids (SCFAs) but increased plasma SCFAs were observed in patients with Parkinson's disease
with #Parkinson disease (PD) and these changes were associated to changes in the gut microbiota and...